US HB8211 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Republican 9-0)
Status: Introduced on May 1 2024 - 25% progression
Action: 2024-05-01 - Referred to the House Committee on the Judiciary.
Pending: House Judiciary Committee
Status: Introduced on May 1 2024 - 25% progression
Action: 2024-05-01 - Referred to the House Committee on the Judiciary.
Pending: House Judiciary Committee
Summary
To amend title 18, United States Code, to prohibit former employees of covered health agencies from serving on the board of entities involved in development and research of a drug, biological product, or device and from profiting from a drug, biological product, or device, and for other purposes.
Title
To amend title 18, United States Code, to prohibit former employees of covered health agencies from serving on the board of entities involved in development and research of a drug, biological product, or device and from profiting from a drug, biological product, or device, and for other purposes.
Sponsors
Rep. Debbie Lesko [R-AZ] | Rep. Andy Biggs [R-AZ] | Rep. Greg Steube [R-FL] | Rep. Diana Harshbarger [R-TN] |
Rep. Doug LaMalfa [R-CA] | Rep. Joe Wilson [R-SC] | Rep. Dan Bishop [R-NC] | Rep. Jeff Duncan [R-SC] |
Rep. Michelle Fischbach [R-MN] |
History
Date | Chamber | Action |
---|---|---|
2024-05-01 | House | Referred to the House Committee on the Judiciary. |
2024-05-01 | House | Introduced in House |
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/house-bill/8211/all-info |